DrugPatentWatch Database Preview
Mometasone furoate - Generic Drug Details
What are the generic sources for mometasone furoate and what is the scope of mometasone furoate patent protection?
Mometasone furoate
is the generic ingredient in six branded drugs marketed by Merck Sharp Dohme, Anda Repository, Fougera Pharms, G And W Labs, Glenmark Generics, Taro, Intersect Ent Inc, Perrigo Israel, Perrigo New York, Torrent Pharms Ltd, Amneal Pharms, and Apotex Inc, and is included in twenty-seven NDAs. There are thirteen patents protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.There are thirty drug master file entries for mometasone furoate. Twenty-one suppliers are listed for this compound.
Summary for mometasone furoate
| US Patents: | 13 |
| Tradenames: | 6 |
| Applicants: | 12 |
| NDAs: | 27 |
| Drug Master File Entries: | 30 |
| Suppliers / Packagers: | 21 |
| Bulk Api Vendors: | 56 |
| Clinical Trials: | 93 |
| Patent Applications: | 6,485 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for mometasone furoate |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for mometasone furoate |
| DailyMed Link: | mometasone furoate at DailyMed |
Pharmacology for mometasone furoate
| Drug Class | Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
Medical Subject Heading (MeSH) Categories for mometasone furoate
Synonyms for mometasone furoate
| (11beta,16alpha)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate |
| (11beta,16alpha)-9,21-Dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methylpregna-1,4-diene-3,20-dione |
| (1R,2S,10S,11S,13R,14R,15S,17S)-1-CHLORO-14-(2-CHLOROACETYL)-17-HYDROXY-2,13,15-TRIMETHYL-5-OXOTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADECA-3,6-DIEN-14-YL FURAN-2-CARBOXYLATE |
| (8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate |
| (9beta,10alpha,11alpha,14beta,16alpha,17alpha)-9,21-dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate |
| [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloranyl-17-(2-chloranylethanoyl)-10,13,16-trimethyl-11-oxidanyl-3-oxidanylidene-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate |
| [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloroacetyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate |
| 04201GDN4R |
| 11?,16?)-9,21-Dichloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl 2-furoate |
| 2-furancarboxylic acid [(8S,9R,10S,11S,13S,14S,16R,17R)-9-chloro-17-(2-chloro-1-oxoethyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] ester |
| 83919-23-7 |
| 9,21-dichloro-11beta-hydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-17-yl furan-2-carboxylate |
| 9,21-Dichloro-11beta,17-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 17-(2-furoate) |
| 919M237 |
| A840685 |
| AB2000407 |
| AC-941 |
| AC1L9AZS |
| AK163902 |
| AKOS015994732 |
| AN-15438 |
| Asmanex |
| Asmanex HFA |
| Asmanex Twisthaler |
| BC228151 |
| BDBM50148733 |
| BPBio1_000424 |
| BRD-K60640630-001-03-7 |
| BRN 4340538 |
| BSPBio_000384 |
| C07817 |
| C27H30Cl2O6 |
| CAS-83919-23-7 |
| CCG-220572 |
| CHEBI:47564 |
| CHEMBL1161 |
| CS-2389 |
| D00690 |
| Danitin |
| DR003147 |
| DSSTox_CID_3333 |
| DSSTox_GSID_23333 |
| DSSTox_RID_76981 |
| DTXSID4023333 |
| Ecural |
| Elocon |
| Elocone |
| Elomet |
| Flumeta |
| HMS1569D06 |
| HMS2096D06 |
| HMS2235I14 |
| HY-13693 |
| KS-00000SPL |
| KS-1275 |
| LAS 41002 |
| M2354 |
| MLS002153879 |
| MolPort-003-849-257 |
| Mometasone 17-(2-furoate) |
| mometasone 17-furoate |
| mometasone furancarboxylate |
| Mometasone furoate (JAN/USP) |
| Mometasone furoate [USAN:USP:JAN] |
| Mometasone furoate hydrate |
| Mometasone Furoate Impurity G |
| MOMETASONE FUROATE MONOHYDRATE |
| Mometasone furoate, >=98% (HPLC) |
| Mometasone furoate, European Pharmacopoeia (EP) Reference Standard |
| Mometasone Furoate, pharmaceutical secondary standard; traceable to USP, PhEur and BP |
| Mometasone furoate, United States Pharmacopeia (USP) Reference Standard |
| Monovo |
| Nasonex |
| NCGC00016950-01 |
| NCGC00179578-01 |
| NCGC00179578-03 |
| NCGC00179578-04 |
| Nosorex |
| NSC-746171 |
| NSC746171 |
| Ovixan |
| PL071566 |
| Pregna-1,20-dione, 9,21-dichloro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16-methyl-, (11.beta.,16.alpha.)- |
| Pregna-1,4-diene-3,20-dione, 9,21-dichloro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methyl-, (11beta,16alpha)- |
| Prestwick_924 |
| Prestwick0_000572 |
| Prestwick1_000572 |
| Prestwick2_000572 |
| Prestwick3_000572 |
| Q-101380 |
| Rimelon |
| s1987 |
| Sch 32088 |
| Sch-32088 |
| SCHEMBL4568 |
| Sinuva |
| SMR001233233 |
| SPBio_002603 |
| SR-01000841209 |
| SR-01000841209-2 |
| ST24048112 |
| TL8005500 |
| Tox21_110705 |
| Tox21_110705_1 |
| UNII-04201GDN4R |
| WOFMFGQZHJDGCX-ZULDAHANSA-N |
| ZINC3938677 |
US Patents and Regulatory Information for mometasone furoate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Anda Repository | MOMETASONE FUROATE | mometasone furoate | LOTION;TOPICAL | 076499-001 | Nov 21, 2007 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Intersect Ent Inc | SINUVA | mometasone furoate | IMPLANT;IMPLANTATION | 209310-001 | Dec 8, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Apotex Inc | MOMETASONE FUROATE | mometasone furoate | SPRAY, METERED;NASAL | 091161-001 | Mar 22, 2016 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Glenmark Generics | MOMETASONE FUROATE | mometasone furoate | LOTION;TOPICAL | 090506-001 | Aug 9, 2010 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Taro | MOMETASONE FUROATE | mometasone furoate | LOTION;TOPICAL | 076788-001 | Mar 15, 2006 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for mometasone furoate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck Sharp Dohme | ASMANEX HFA | mometasone furoate | AEROSOL, METERED;INHALATION | 205641-002 | Apr 25, 2014 | ➤ Sign Up | ➤ Sign Up |
| Merck Sharp Dohme | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-002 | Feb 1, 2008 | ➤ Sign Up | ➤ Sign Up |
| Merck Sharp Dohme | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-001 | Mar 30, 2005 | ➤ Sign Up | ➤ Sign Up |
| Merck Sharp Dohme | ASMANEX TWISTHALER | mometasone furoate | POWDER;INHALATION | 021067-002 | Feb 1, 2008 | ➤ Sign Up | ➤ Sign Up |
| Merck Sharp Dohme | NASONEX | mometasone furoate | SPRAY, METERED;NASAL | 020762-001 | Oct 1, 1997 | ➤ Sign Up | ➤ Sign Up |
| Merck Sharp Dohme | ASMANEX HFA | mometasone furoate | AEROSOL, METERED;INHALATION | 205641-001 | Apr 25, 2014 | ➤ Sign Up | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
International Patents for mometasone furoate
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Spain | 2065701 | ➤ Sign Up |
| Croatia | P920383 | ➤ Sign Up |
| Australia | 2009276505 | ➤ Sign Up |
| European Patent Office | 2298318 | ➤ Sign Up |
| Hungary | 9300685 | ➤ Sign Up |
| Ireland | 67056 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for mometasone furoate
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 5/1998 | Austria | ➤ Sign Up | PRODUCT NAME: MOMETASON FUROAT MONOHYDRAT |
| 875032 | Germany | ➤ Sign Up | PRODUCT NAME: MOMETASON-FUROAT-MONOHYDRAT; NAT. REGISTRATION NO/DATE: 40803.00.00 19980218; FIRST REGISTRATION: FRANKREICH NL 22055 19970219 |
| 0012 | Netherlands | ➤ Sign Up | 980012, 20110905, EXPIRES: 20160905 |
| 1998 | Austria | ➤ Sign Up | PRODUCT NAME: MOMETASON FUROAT MONOHYDRAT; NAT. REGISTRATION NO/DATE: 1-22208 19971111; FIRST REGISTRATION: FR AMM 343012.6 19970219 |
| C/GB97/064 | United Kingdom | ➤ Sign Up | PRODUCT NAME: MOMETASONE FUROATE MONOHYDRATE; REGISTERED: FR AMM 343012.6 19970219; UK 00201/0216 19970410 |
| 80012 | Netherlands | ➤ Sign Up | PRODUCT NAME: MOMETASONI FUROAS MONOHYDRATUM; NAT. REGISTRATION NO/DATE: RVG 21613 19971209; FIRST REGISTRATION: FR NL22055 19970219 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: